Insulin + Islet Cell Antigen

Optimal result: 0.5 – 1.9 ELISA Index

Clinical Significance: Diabetes mellitus is generally classified as either Type 1 (insulin dependent diabetes mellitus) or Type 2 (non-insulin dependent diabetes mellitus). In most instances, the onset of Type 1 diabetes mellitus (T1DM) is the result of autoimmune destruction of insulin-producing beta cells in the pancreatic islets and the ensuing loss of endogenous insulin secretion.

IA-2, previously known as ICA-512, is an important target of autoantibodies associated with the development of T1DM.

Measurement of these immunologic markers has been shown to be of considerable value in assisting the attending clinician with the diagnosis of patients with diabetes. Multiple islet cell antibodies (ICAs) at diagnosis of diabetes can predict future complete betacell failure; after diagnosis ICA development in patients who were antibody negative at diagnosis indicate decreasing beta-cell function. ICAs may precede diabetic symptoms by several years, even in people with normal glucose tolerance, but these titers are not always followed by diabetes. ICAs are often present at or soon after the clinical onset of insulin-dependent diabetes, but their prevalence decreases thereafter.

Associated with:

- Insulinoma

- Type 1 Diabetes

- Unexplained Hypoglycemia

- Latent Autoimmune Diabetes of Adults

Function: Islet cells are found in the region of the pancreas that contains its hormone-producing cells. Hormones produced in the islets are secreted directly into the blood flow by different types of cells including the beta-cell. Insulin is a hormone that plays a role in the regulation of carbohydrate and fat metabolism.

Known Cross-Reactions: Islet Cell Antigen (ICA) with Coxsackievirus, Seaweed, Guar gum, Apricot, Pea Lectin, Spinach, Cooked white and brown Rice, Cooked Garlic, Zucchini, Mackerel, Egg yolk, Garbanzo bean, Carrageenan, Soybean agglutinin, Bell Pepper, Mint

Antibodies Appear:

- Type 1 Diabetes

- Unexplained Hypoglycaemia

Clinical Significance: Diabetes mellitus is generally classified as either Type 1 (insulin dependent diabetes mellitus) or Type 2 (non-insulin dependent diabetes mellitus). In most instances, the onset of Type 1 diabetes mellitus (T1DM) is the result of autoimmune destruction of insulin-producing beta cells in the pancreatic islets and the ensuing loss of endogenous insulin secretion.

IA-2, previously known as ICA-512, is an important target of autoantibodies associated with the development of T1DM.

Measurement of these immunologic markers has been shown to be of considerable value in assisting the attending clinician with the diagnosis of patients with diabetes. Multiple islet cell antibodies (ICAs) at diagnosis of diabetes can predict future complete betacell failure; after diagnosis ICA development in patients who were antibody negative at diagnosis indicate decreasing beta-cell function. ICAs may precede diabetic symptoms by several years, even in people with normal glucose tolerance, but these titers are not always followed by diabetes. ICAs are often present at or soon after the clinical onset of insulin-dependent diabetes, but their prevalence decreases thereafter.

References:

Törn et al. Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia 2008 51:846-852.

Chen et al. Sensitive non isotopic assays for autoantibodies to IA-2 and to a combination of both IA-2 and GAD-65. Clinica Chimica Acta 2005 357:74-83.

Pardini, et al. Frequency of islet cell autoantibodies (IA-2 and GAD) in young Brazilian Type 1 diabetes patients. Brazilian Journal of Medical and Biological Research, 1999, 32:1195-1198.

Lendrum, et al. Islet-cell, thyroid, and gastric autoantibodies in diabetic identical twins. Br Med J, 1976, 1:553-556.

Kharrazian, et al. Detection of islet cell immune reactivity with low glycemic index foods: is this a concern for Type 1 diabetes? J Diabetes Res, 2017; 2017:4124967.

Härkönen, et al. Enterovirus infection can induce immune responses that cross-react with beta-cell autoantigen tyrosine phosphatase IA-2/IAR. J Med Virol, 2002; 66(3):340-350.

Insulin + Islet Cell Antigen
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Insulin + Islet Cell Antigen — 10,000+ markers explained
One Insulin + Islet Cell Antigen result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro